Anjulika Chawla
bluebird bio, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anjulika Chawla as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:58 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04628585 · Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyGenetix Biotherapeutics Inc. · enrolling by invitation · Sickle Cell Disease · study director
- Ph3NCT04293185 · A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell DiseaseGenetix Biotherapeutics Inc. · active not recruiting · Sickle Cell Disease · study director
- Ph1/Ph2NCT02140554 · A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell DiseaseGenetix Biotherapeutics Inc. · completed · Sickle Cell Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:58 UTC. The ranking covers the 200 most relevant of 38 PubMed records, and a shared surname and initials can bring in a namesake. All 38 on PubMed
- Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.Radiology · 2013266 citationsRCR 9.0
- Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial.J Gastroenterol Hepatol · 2003207 citationsRCR 5.8
- 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.J Am Coll Cardiol · 2023161 citationsRCR 20.4
- Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.J Clin Oncol · 2025112 citationsRCR 23.8
- 99 citationsRCR 5.2
- Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.Transfusion · 201261 citationsRCR 2.7
- Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.Haematologica · 201960 citationsRCR 2.9
- Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.Clin Pharmacol Ther · 201753 citationsRCR 2.1
- Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5.Acta Odontol Scand · 201149 citationsRCR 2.3
- Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.Int J Radiat Oncol Biol Phys · 201633 citationsRCR 1.1